When is $100 million not $100 million? When it’s a proxy, maybe even something akin to a bet.The nice, round figure is the target initial public offering value for Editas Medicine, a biotechnology firm with a mission of using gene editing to treat disease. The company has already raised more than $160 million from investors, and initial evaluations of the IPO said it was almost certain to be exceeded when the stock started trading publicly.But Editas could face a big problem.
The Battle Over Crispr Could Make Or Break Some Biotech Companies
Farai Chideya, FiveThirtyEight: Science & Health
Mon, 01/25/2016 - 4:18am
Topics: editas medicine crispr,18 u.s patent miguel riopa /afp getty images susan walsh apcrispr microsoft word robin feldman law as crispr/cas9 hiv dna thomson reuters ivf montana state university current opinion virology june horizon discovery group caribou biosciences editas in march america invents act a emmanuelle paul leiman johns hopkins university s carey business school myriad genetics brca november new yorker hitler holocaust u.s in investigative reporting california department corrections rehabilitation at asperger s marcy darnovsky society gattaca that congress europe canada australia mexico brazil march chinese nature international summit human gene editing dana carroll utah god joi ito mit media lab those uc trademark office s doudna s anne li correction jan editas in as a medicine ipo crispr broad institute mit harvard u.s patent trademark office university california charpentier dna jennifer doudna feng zhang an cas9 rna hastings crispr science sciences therapeutics the doudna genetics supreme court center darnovsky national academy technology scientists technologies fight billion biotechnology people property million move system embryos genes public genome work firms director seek time eugenics set promise month long question choose ruled holder millions questions conference dispute money risk hundreds government file history high guide species scientific helix mix sector
Welcome to Wopular
Wopular is an
online newspaper rack,
giving you a summary view of the top headlines from the top news sites.
Senh Duong (Founder)
Wopular,
MWB,
RottenTomatoes
MoviesWithButter : Our Sister Site
- "Expendables 4" Starts Shooting This Fall, Says Randy Couture at the Arnold Sports Festival more
- “Expendables 4” Gets Funding Interest from “Ip Man 3” Financier more
- "Ip Man 3" Distributor Suspected of Box Office Fraud, Parent Company Loses $200M in Market Cap more
- Yen Targets "Ip Man 4" for 2018 Release; Discusses Film with Director, Producer more
- "Ip Man 3" Shatters Expectations with $72M Opening [China Box Office] more